Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

At the recent American Society of Hematology annual meeting, researchers presented preclinical data examining how ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell-known as helper T cells-from stem cells in a ...

H 2026 Catalyst Stack Anticipated to Validate Scalable, Off-the-Shelf CAR T in Oncology and Autoimmune DiseaseInterim Futility Analysis of MRD Clearance from the Pivotal Phase 2 ALPHA3 Trial with ...

Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for ...

The fear of cancer stems from the dread that it can recur at any time, even after treatment. A South Korean research team has ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...

Researchers have unlocked a way to grow the immune system’s “conductors” from stem cells, bringing ready-made cancer-fighting therapies a big step closer. For the first time, scientists at the Univers ...